Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice

Hyperdynamic Microtubules, Cognitive Deficits, and Pathology Are Improved in Tau Transgenic Mice with Low Doses of the Microtubule-Stabilizing Agent BMS-241027

(2012) D. M. Barten et al.   JOURNAL OF NEUROSCIENCE

The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice

(2012) B. Zhang et al.   JOURNAL OF NEUROSCIENCE

The deletion of STOP/MAP6 protein in mice triggers highly altered mood and impaired cognitive performances

(2011) Vincent Fournet et al.   JOURNAL OF NEUROCHEMISTRY

Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: Effects of fluoxetine and MK-801

(2011) Séverine Farley et al.   NEUROPHARMACOLOGY

The deletion of the microtubule-associated STOP protein affects the serotonergic mouse brain network

(2010) Vincent Fournet et al.   JOURNAL OF NEUROCHEMISTRY

Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy

(2010) K. R. Brunden et al.   JOURNAL OF NEUROSCIENCE

Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome

(2010) P. Bianchi et al.   JOURNAL OF NEUROSCIENCE

Dysbindin (DTNBP1) – A role in psychotic depression?

(2010) Katharina Domschke et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Erratum: Nitric Oxide Synthase Mediates the Ability of Darbepoetin Alfa to Improve the Cognitive Performance of STOP Null Mice

(2010) Kosuke Kajitani et al.   NEUROPSYCHOPHARMACOLOGY

NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse—A microtubule-deficient model of schizophrenia

(2010) Avia Merenlender-Wagner et al.   PEPTIDES

The microtubule cytoskeleton acts as a key downstream effector of neurotransmitter signaling

(2010) John Gardiner et al.   SYNAPSE

Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice

(2009) David Delotterie et al.   PSYCHOPHARMACOLOGY

Fluoxetine administration modulates the cytoskeletal microtubular system in the rat hippocampus

(2009) Massimiliano Bianchi et al.   SYNAPSE

Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey

(2008) Ipek Yalcin et al.   BEHAVIOURAL BRAIN RESEARCH

Therapeutic Potential of Fluoxetine in Neurological Disorders

(2008) Jop P. Mostert et al.   CNS Neuroscience & Therapeutics

The Burden of Mental Disorders

(2008) W. W. Eaton et al.   EPIDEMIOLOGIC REVIEWS

Common risk genes for affective and schizophrenic psychoses

(2008) Wolfgang Maier   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke

(2008) Wen-Lei Li et al.   JOURNAL OF NEUROSCIENCE RESEARCH

A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease

(2008) Y. Matsuoka et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Corticosteroid–serotonin interactions in the neurobiological mechanisms of stress-related disorders

(2008) Laurence Lanfumey et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice

(2008) Oguz Mutlu et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR